FINWIRES · TerminalLIVE
FINWIRES

Leerink Partners Upgrades Replimune Group to Outperform From Market Perform, Adjusts Price Target to $17 From $11

By

Replimune Group (REPL) has an average rating of buy and mean price target of $15.20, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles